Researchers in Sweden and Finland have created the CORE model, a simple blood test that predicts liver disease risk with striking accuracy. Unlike current methods, it works for the general population and can be used in everyday primary care settings. With validation across multiple countries and a web tool already available, the breakthrough could lead to much earlier detection of cirrhosis and liver cancer.
Researchers in Sweden and Finland have created the CORE model, a simple blood test that predicts liver disease risk with striking accuracy. Unlike current methods, it works for the general population and can be used in everyday primary care settings. With validation across multiple countries and a web tool already available, the breakthrough could lead to much earlier detection of cirrhosis and liver cancer. Researchers in Sweden and Finland have created the CORE model, a simple blood test that predicts liver disease risk with striking accuracy. Unlike current methods, it works for the general population and can be used in everyday primary care settings. With validation across multiple countries and a web tool already available, the breakthrough could lead to much earlier detection of cirrhosis and liver cancer.